Monosodium glutamate (MSG): A villain and promoter of liver inflammation and dysplasia

Journal of Autoimmunity

Volumn 30, Issue 1-2, 2008, Pages 42-50

  Nakanishi, Yuko ^a   Tsuneyama, Koichi ^a   Fujimoto, Makoto ^a   Salunga, Thucydides L ^a,b   Nomoto, Kazuhiro ^a   An, Jun Ling ^a   Takano, Yasuo ^a   Iizuka, Seiichi ^c   Nagata, Mitsunobu ^c   Suzuki, Wataru ^c   Shimada, Tsutomu ^c   Aburada, Masaki ^c   Nakano, Masayuki ^e   Selmi, Carlo ^d,f   Gershwin, M Eric ^f  

^a UNIVERSITY OF TOYAMA   (Japan)

^b University of the Philippines Diliman   (Philippines)

^c MUSASHINO UNIVERSITY   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION CHIBA MEDICAL CENTER   (Japan)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diabetes mellitus; Liver steatosis; Nonalcoholic steatohepatitis; Obesity

Indexed keywords

GLUTAMATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DYSPLASIA; FATTY LIVER; FEMALE; FOOD CHAIN; HEPATITIS; HISTOLOGY; LIVER PARENCHYMA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANIMALS; DIABETES MELLITUS, TYPE 2; FATTY LIVER; HEPATITIS, TOXIC; HUMANS; LIVER; LIVER CIRRHOSIS; MICE; OBESITY; SODIUM GLUTAMATE;

EID: 38049028313     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2007.11.016     Document Type: Article

References (47)

1. Abou-Raya A., and Abou-Raya S. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun Rev 5 (2006) 331-337
2. Abbas A.K., Lohr J., and Knoechel B. Balancing autoaggressive and protective T cell responses. J Autoimmun 28 (2007) 59-61
3. Ong J.P., and Younossi Z.M. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis 11 (2007) 1-16 vii
4. Farrell G.C., and Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 (2006) S99-S112
5. Brunt E.M. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21 (2001) 3-16
6. Bugianesi E. Non-alcoholic steatohepatitis and cancer. Clin Liver Dis 11 (2007) 191-207 x-xi
7. Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol 2 (2004) 1048-1058
8. Day C.P., and James O.F. Steatohepatitis: a tale of two "hits" ?. Gastroenterology 114 (1998) 842-845
9. Anstee Q.M., and Goldin R.D. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 87 (2006) 1-16
10. Beyreuther K., Biesalski H.K., Fernstrom J.D., Grimm P., Hammes W.P., Heinemann U., et al. Consensus meeting: monosodium glutamate - an update. Eur J Clin Nutr 61 (2007) 304-313
11. Nagata M., Suzuki W., Iizuka S., Tabuchi M., Maruyama H., Takeda S., et al. Type 2 diabetes mellitus in obese mouse model induced by monosodium glutamate. Exp Anim 55 (2006) 109-115
12. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005) 1313-1321
13. Lobstein T., and Jackson-Leach R. Estimated burden of paediatric obesity and co-morbidities in Europe. Part 2. Numbers of children with indicators of obesity-related disease. Int J Pediatr Obes 1 (2006) 33-41
14. Lapierre P., Beland K., Djilali-Saiah I., and Alvarez F. Type 2 autoimmune hepatitis murine model: the influence of genetic background in disease development. J Autoimmun 26 (2006) 82-89
15. Persson-Sjogren S., Lejon K., Holmberg D., and Forsgren S. Expression of the NK-1 receptor on islet cells and invading immune cells in the non-obese diabetic mouse. J Autoimmun 24 (2005) 269-279
16. Flegal K.M., Carroll M.D., Ogden C.L., and Johnson C.L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 (2002) 1723-1727
17. Akatsuka T., Kobayashi N., Ishikawa T., Saito T., Shindo M., Yamauchi M., et al. Autoantibody response to microsomal epoxide hydrolase in hepatitis C and A. J Autoimmun 28 (2007) 7-18
18. Salunga T.L., Cui Z.G., Shimoda S., Zheng H.C., Nomoto K., Kondo T., et al. Oxidative stress-induced apoptosis of bile duct cells in primary biliary cirrhosis. J Autoimmun 29 (2007) 78-86
19. Hahn B.H., Grossman J., Chen W., and McMahon M. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J Autoimmun 28 (2007) 69-75
20. Gebe JA, Unrath KA, Yue BB, Miyake T, Falk BA, Nepom GT. Autoreactive human T-cell receptor initiates insulitis and impaired glucose tolerance in HLA DR4 transgenic mice. J Autoimmun, in press. doi:10.1016/j.jaut.2007.08.001.
21. Washburn L.R., Dang H., Tian J., and Kaufman D.L. The postnatal maternal environment influences diabetes development in nonobese diabetic mice. J Autoimmun 28 (2007) 19-23
22. Weltman M.D., Farrell G.C., and Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 111 (1996) 1645-1653
23. Deng Q.G., She H., Cheng J.H., French S.W., Koop D.R., Xiong S., et al. Steatohepatitis induced by intragastric overfeeding in mice. Hepatology 42 (2005) 905-914
24. Ogden C.L., Yanovski S.Z., Carroll M.D., and Flegal K.M. The epidemiology of obesity. Gastroenterology 132 (2007) 2087-2102
25. Imhof A., Kratzer W., Boehm B., Meitinger K., Trischler G., Steinbach G., et al. Prevalence of non-alcoholic fatty liver and characteristics in overweight adolescents in the general population. Eur J Epidemiol (2007) Published online 10.1007/s10654-007-9181-7
26. Hewitt K.N., Pratis K., Jones M.E., and Simpson E.R. Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. Endocrinology 145 (2004) 1842-1848
27. Clark J.M., Brancati F.L., and Diehl A.M. Nonalcoholic fatty liver disease. Gastroenterology 122 (2002) 1649-1657
28. Caldwell S.H., Oelsner D.H., Iezzoni J.C., Hespenheide E.E., Battle E.H., and Driscoll C.J. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 29 (1999) 664-669
29. Nanda K. Non-alcoholic steatohepatitis in children. Pediatr Transplant 8 (2004) 613-618
30. Yatsuji S., Hashimoto E., Kaneda H., Taniai M., Tokushige K., and Shiratori K. Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the international autoimmune hepatitis group scoring system useful?. J Gastroenterol 40 (2005) 1130-1138
31. Adams L.A., Lindor K.D., and Angulo P. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 99 (2004) 1316-1320
32. Agostoni C., Carratu B., Boniglia C., Riva E., and Sanzini E. Free amino acid content in standard infant formulas: comparison with human milk. J Am Coll Nutr 19 (2000) 434-438
33. Branum A.M., Collman G.W., Correa A., Keim S.A., Kessel W., Kimmel C.A., et al. The national children's study of environmental effects on child health and development. Environ Health Perspect 111 (2003) 642-646
34. Gleicher N., and Barad D.H. Gender as risk factor for autoimmune diseases. J Autoimmun 28 (2007) 1-6
35. Wicker L.S., Clark J., Fraser H.I., Garner V.E., Gonzalez-Munoz A., Healy B., et al. Type 1 diabetes genes and pathways shared by humans and NOD mice. J Autoimmun 25 Suppl. (2005) 29-33
36. Bach J.F. Infections and autoimmune diseases. J Autoimmun 25 Suppl. (2005) 74-80
37. Abraham M., Karni A., Dembinsky A., Miller A., Gandhi R., Anderson D., et al. In vitro induction of regulatory T cells by anti-CD3 antibody in humans. J Autoimmun 30 (2008) 21-28
38. Andreoli L., Pregnolato F., Burlingame R., Allegri F., Rizzini S., Fanelli V., et al. Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity. J Autoimmun 30 (2008) 51-57
39. Binard A., Le Pottier L., Saraux A., Devauchelle-Pensec V., Pers J.-O., and Youinou P. Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?. J Autoimmun 30 (2008) 63-67
40. Jacobson E., Huber A., and Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 30 (2008) 58-62
41. Kallenberg C. Pathogenesis of PR3-ANCA associated vasculitis. J Autoimmun 30 (2008) 29-36
42. Mackay I.R., Leskovsek N., and Rose N.R. Cell damage and autoimmunity: a critical appraisal. J Autoimmun 30 (2008) 5-11
43. Poletaev A., Stepanyuk V., and Gershwin M. Integrating immunity: the immunculus and self reactivity. J Autoimmun 30 (2008) 68-73
44. Praprotnik S., Snezna S.-S., Tomsic M., and Shoenfeld Y. The curiously suspicious: infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients. J Autoimmun 30 (2008) 37-41
45. Recalcati S., Invernizzi P., Arosio P., and Cairo G. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun 30 (2008) 84-89
46. Sanchez-Pernaute O., Ospelt C., Neidhart M., and Gay S. Epigenetic clues to rheumatoid arthritis. J Autoimmun 30 (2008) 12-20
47. Shoenfeld Y., and Gershwin M. Autoimmunity: from the mosaic to the kaleidoscope. J Autoimmun 30 (2008) 1-4